Tom R. Hodgson
Keine laufenden Positionen mehr
Profil
Tom R.
Hodgson served as the President & Chief Operating Officer of Abbott Laboratories from 1972 to 1998.
He was also the President of Abbott International LLC from 1983 to 1990.
He later served as the Chairman of Idenix Pharmaceuticals LLC from 2012 to 2014.
Additionally, he was a Director at InterMune, Inc. and Pelion Venture Partners, and an Independent Director at The Travelers Cos., Inc. Hodgson received his undergraduate degree from Purdue University, his graduate degree from the University of Michigan, and his MBA from Harvard Business School.
Ehemalige bekannte Positionen von Tom R. Hodgson
| Unternehmen | Position | Ende |
|---|---|---|
| IDENIX PHARMACEUTICALS INC | Vorsitzender | 01.08.2014 |
| INTERMUNE INC | Direktor/Vorstandsmitglied | 25.05.2006 |
| ABBOTT LABORATORIES | Präsident | 01.01.1998 |
| Abbott International LLC | Präsident | 01.01.1990 |
Pelion Venture Partners
 Pelion Venture Partners Investment ManagersFinance Pelion Venture Partners (Pelion Venture Partners) is a venture capital firm founded in 1986 by Jim C. Dreyfous and Joel D. Kellman. The firm is headquartered in Salt Lake City. Utah. | Mitglied des Investmentausschusses | - |
Ausbildung von Tom R. Hodgson
| Purdue University | Undergraduate Degree |
| University of Michigan | Graduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| THE TRAVELERS COMPANIES | Finance |
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 5 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Wind Point Advisors LLC
 Wind Point Advisors LLC Investment ManagersFinance Wind Point Advisors LLC (Wind Point Advisors) is a private equity firm founded in 1984 by Rich Kracum and Bob Cummings. The firm is headquartered in Chicago, Illinois. | Finance |
Pelion Venture Partners
Pelion Venture Partners Investment ManagersFinance Pelion Venture Partners (Pelion Venture Partners) is a venture capital firm founded in 1986 by Jim C. Dreyfous and Joel D. Kellman. The firm is headquartered in Salt Lake City. Utah. | Finance |
| Abbott International LLC |
